Form 4 for MDGL MADRIGAL PHARMACEUTICALS, INC.
Accepted 2025-04-11 00:00:00 ET · period of report 2025-04-10 · accession 0001628280-25-017563 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-11 | 2025-04-10 | MDGL | Levy Richard S | Dir | M - OptEx | $65.06 | +9,470 | 20.5K | +86% | +$616.1K |
| D | 2025-04-11 | 2025-04-10 | MDGL | Levy Richard S | Dir | M - OptEx | $0.00 | -9,470 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-10 | M | A | 9,470 | $65.06 | 20,482 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-04-10 | M | D | 9,470 | $0.00 | 0 | D | $65.06 · — to 2025-06-16 | 9,470 Common Stock | (F1) The shares underlying this stock option are fully vested and exercisable |